Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials (Q33897188)

29 July 2017

0 references

Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials (English)

1 reference

29 July 2017

arterial hypertension

0 references

0 references

1 reference

systolic hypertension

1 reference

1

J A Staessen

1 reference

29 July 2017

L Thijs

4

0 references

author name string

J Gasowski

2

1 reference

29 July 2017

J G Wang

3

1 reference

29 July 2017

E Den Hond

5

1 reference

29 July 2017

J P Boissel

6

1 reference

29 July 2017

J Coope

7

1 reference

29 July 2017

T Ekbom

8

1 reference

29 July 2017

F Gueyffier

9

1 reference

29 July 2017

L Liu

10

1 reference

29 July 2017

K Kerlikowske

11

1 reference

29 July 2017

S Pocock

12

1 reference

29 July 2017

R H Fagard

13

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 March 2000

1 reference

29 July 2017

1 reference

29 July 2017

355

1 reference

29 July 2017

865-872

1 reference

29 July 2017

9207

1 reference

Isolated systolic hypertension in the elderly

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2907330-4

7 January 2021

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2907330-4

7 January 2021

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2907330-4

7 January 2021

Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2907330-4

7 January 2021

Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2907330-4

7 January 2021

Randomised trial of treatment of hypertension in elderly patients in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2907330-4

7 January 2021

Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2907330-4

7 January 2021

Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2907330-4

7 January 2021

MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2907330-4

7 January 2021

Blood pressure, stroke, and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2907330-4

7 January 2021

Treatment of hypertension in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2907330-4

7 January 2021

Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2907330-4

7 January 2021

Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. INDANA Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2907330-4

7 January 2021

Hypertension in the elderly. Implications and generalizability of randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2907330-4

7 January 2021

Drug treatment of hypertension in the elderly: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2907330-4

7 January 2021

Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2907330-4

7 January 2021

Are β-Blockers Efficacious as First-line Therapy for Hypertension in the Elderly?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2907330-4

7 January 2021

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2907330-4

7 January 2021

Prospective study on the treatment of mild hypertension in the aged

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2907330-4

7 January 2021

Effect of antihypertensive treatment on stroke recurrence. Hypertension-Stroke Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2907330-4

7 January 2021

Five-year findings of the hypertension detection and follow-up program. II. Mortality by race-sex and age. Hypertension Detection and Follow-up Program Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2907330-4

7 January 2021

Analysis of serial measurements in medical research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2907330-4

7 January 2021

Relation between mortality and treated blood pressure in elderly patients with hypertension: report of the European Working Party on High Blood Pressure in the Elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2907330-4

7 January 2021

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2907330-4

7 January 2021

Pulse pressure as a risk factor for cardiovascular events in the MRC Mild Hypertension Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2907330-4

7 January 2021

Simple blood pressure guidelines for primary health care

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2907330-4

7 January 2021

Blood pressure and twenty-year mortality in the city of Bergen, Norway

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2907330-4

7 January 2021

Blood pressure in the very old.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2907330-4

7 January 2021

Subgroup and per-protocol analysis of the randomized European Trial on Isolated Systolic Hypertension in the Elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2907330-4

7 January 2021

Benefits and potential harm of lowering high blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2907330-4

7 January 2021

The role of diastolic blood pressure when treating isolated systolic hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2907330-4

7 January 2021

Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2907330-4

7 January 2021

Antihypertensive effect of sustained-release isosorbide dinitrate for isolated systolic systemic hypertension in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2907330-4

7 January 2021

10.1016/S0140-6736(99)07330-4

Identifiers

DOI

1 reference

29 July 2017

1 reference